4,、Moderna Therapeutics

成立時(shí)間：2010年

已募集的風(fēng)投資金：8.639億美元

估值：30億美元

簡(jiǎn)介：Moderna是一家生物技術(shù)公司，致力于研究信使RNA,，以期治療腫瘤,、傳染病和罕見(jiàn)疾病,。該公司創(chuàng)造了生物技術(shù)初創(chuàng)公司單輪風(fēng)投融資的歷史記錄：今年1月融資4.5億美元。

盡管Moderna目前還沒(méi)有任何一種藥進(jìn)入人體試驗(yàn)階段,，但公司卻因其革命性的提議吸引了風(fēng)險(xiǎn)投資家的目光：幫助人們用自身細(xì)胞產(chǎn)生藥物,，這可能催生各種更易于測(cè)試，價(jià)格更低廉的潛在治療方式,。

4. Moderna Therapeutics

Year founded: 2010

VC money raised: $863.9 million

Valuation: $3 billion

About: Moderna is a biotech company whose research revolves around messenger RNA to develop treatments for oncology, infectious and rare diseases. The company holds the distinction of having raised the largest single round of VC funding ever for a biotech startup: $450 million last January.

While Moderna doesn’t yet have a single drug in human trials, the company has garnered the eye of venture capitalists because its revolutionary proposition is to help people create medicine within their own cells — leading to a massive variety of potential treatments that are faster to test and cheaper to buy.